Monitoring Agency Report for the Quarter ended June 30, 2026

August 03, 2026 BSE Limited National Stock Exchange of India Limited P.J. Tower, Exchange Plaza, Dalal Street, Fort, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 544645 SYMBOL: PARKHOSPS Subject: Disclosure under Regulation 32 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)- Monitoring Agency Report for the Quarter ended June 30, 2026 Dear Sir/Madam, Pursuant to Regulation 32(6) of the Listing Regulations read with Regulation 41(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed herewith the Monitoring Agency Report issued by CRISIL Ratings Limited, the Monitoring Agency, for the Quarter ended June 30, 2026, on the utilization of the proceeds of Initial Public Offering (“IPO”) of the Company. The above report has been placed before and considered by the Board of Directors and Audit Committee at their respective meetings held today i.e. August 03, 2026. The above disclosure is also being made available on the website of the Company at https://www.parkhospital.in/. This is for your information and records. Thanking you, For and on behalf of Park Medi World Limited Name: Abhishek Kapoor Designation: Company Secretary & Compliance Officer Encl: A/a Monitoring Agency Report for Park Medi World Limited for the quarter ended June 30, 2026 CRL/MAR/PRKH/2026-27/1879 August 03, 2026 Park Medi World Limited 12, Meera Enclave, Outer Ring Road, Near Keshopur Bus Depot, Delhi - 110018 Dear Sir/Madam, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Initial Public Offer (“IPO”) of Park Medi World Limited (“the Company”) Pursuant to Regulation 41(2) of SEBI (lssue of Capital and Disclosure Requirements) Regulations, 2018 (“SEBI ICDR Regulations”) and Monitoring Agency Agreement dated August 18, 2025, enclosed herewith the Monitoring Agency Report, issued by Crisil Ratings Limited, Monitoring Agency, as per Schedule XI of the SEBI ICDR Regulations towards utilization of proceeds of IPO for the quarter ended June 30, 2026. Request you to kindly take the same on records. Thanking you, For and on behalf of Crisil Ratings Limited Shounak Chakravarty Director, Ratings (LCG) Report of the Monitoring Agency (MA) Name of the issuer: Park Medi World Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: Crisil Ratings Limited (a) Deviation from the objects: Not applicable (b) Range of Deviation: Not applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit-related analyses. We confirm that we do not perceive any conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Shounak Chakravarty Designation of Authorized person/Signing Authority: Director, Ratings (LCG) 1) Issuer Details: Name of the issuer: Park Medi World Limited Names of the promoter: Dr. Ajit Gupta Dr. Ankit Gupta Industry/sector to which it belongs: Hospital 2) Issue Details Issue Period: Wednesday, December 10, 2025, to Friday, December 12, 2025 Type of issue (public/rights): Initial Public Offer (IPO) Type of specified securities: Equity Shares IPO Grading, if any: NA Issue size: Rs 7,700 million Particulars of the Issue Size Amount (Rs in million) Gross proceeds of the Fresh Issue 7,700.00# Less: Issue Expenses 567.23 Net Proceeds 7,132.77 #Crisil Ratings shall be monitoring the gross proceeds amount. 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information/ Comments certifications Comments of the of the Particulars Reply considered by Monitoring Board of Monitoring Agency Agency Directors for preparation of report Statutory Auditor’s certificate^, Management undertaking, Proceeds were Whether all utilization is as per the Prospectus dated utilized towards No disclosures in the Offer Document? December 12, 2025 capital expenditure Comments (hereinafter by the subsidiary referred as “Offer Document”), Bank Statements Source of information/ Comments certifications Comments of the of the Particulars Reply considered by Monitoring Board of Monitoring Agency Agency Directors for preparation of report Whether shareholder approval has been obtained in case of material deviations from No NA No Comments expenditures disclosed in the Offer Comments Document? Whether the means of finance for the No No No Comments disclosed objects of the issue has changed? Comments Is there any major deviation observed over No No No Comments the earlier monitoring agency reports? Comments Statutory Auditor’s Whether all Government/statutory certificate^, approvals related to the object(s) have been NA Management No Comments Comments obtained? undertaking Whether all arrangements pertaining to technical assistance/collaboration are in NA No Comments Comments operation? Are there any favorable events improving No No No Comments the viability of these object(s)? Comments Are there any unfavorable events affecting No the viability of the object(s)? N o No Comments Comments Is there any other relevant information that may materially affect the decision making of No No Comments Comments the investors? NA represents Not Applicable ^Certificate dated August 01, 2026, issued by M/s Agiwal & Assocaites, Chartered Accountants (Firm Registration Number: 000181N), Statutory Auditors of the Company. 4) Details of object(s) to be monitored: i. Cost of the object(s): Source of Comments of the Board of Original cost information/ Directors (as per the Revised Comment of certification Particulars Sr. Offer Cost the Item considered by Reason of Proposed of firm No. Document) (Rs in Monitoring Head MA for Cost financing arrangemen (Rs in million) Agency preparation of revision option ts million) report made Repayment/ prepayment, in full or in part, of outstanding 1 3,800.00 NA No revision No Comments borrowings availed by the Company and its Subsidiaries Funding capital expenditure for development of new 2 605.00 NA No revision No Comments hospital by the Subsidiary Park Medicity (NCR) St [Showing first 8,000 characters — download PDF for full document]